On January 3, 2024, Santosh Shanbhag submitted his resignation as Treasurer of Akili, Inc. and as principal financial officer (PFO) and principal accounting officer (PAO) of the Company, in each case effective as of January 12, 2024 (the Effective Date), to pursue another business opportunity. Matthew Franklin, the Company?s President and Chief Executive Officer, will assume the duties of PFO and PAO of the Company on the Effective Date. Mr. Franklin, 50, has served as the Company?s President and Chief Executive Officer and a member of the Company?s board of directors since October 2023.

Prior to that, he served as the Company?s President and Chief Operating Officer from August 2022 to October 2023. Mr. Franklin served in the same capacity at legacy Akili from June 2022 until August 2022. Prior to joining the Company, from January 2021 to June 2022, Mr. Franklin served as General Manager of the Precision Oncology business unit at Exact Sciences Corp., a publicly traded molecular diagnostics company.

From March 2020 to January 2021, Mr. Franklin served as Chief Commercial Officer of Thrive Earlier Detection Corp., a healthcare company, where he led the go-to-market strategy development for their multi-cancer early detection assay. From August 2018 to January 2020, Mr. Franklin served as Chief Business Officer of ArcherDX Inc., a growth-stage molecular diagnostics company, where he was responsible for establishing and scaling the global sales, customer support, marketing, market access, business development and corporate development teams. From March 2015 to July 2018, Mr. Franklin served as Senior Vice President of Global Marketing and Clinical Product Strategy of Foundation Medicine Inc., a molecular insights company which was acquired by Roche Holdings, Inc. in 2018. Mr. Franklin holds a B.A. in English Literature from Northwestern University and an MBA from the University of Michigan, Ann Arbor.